Press release content from Business Wire. The AP news staff was not involved in its creation.

Global NGS-based RNA-seq Market to Grow by £3.75 Billion During 2023-2027 -

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
December 22, 2022 GMT

DUBLIN--(BUSINESS WIRE)--Dec 22, 2022--

The “Global NGS-based RNA-seq Market 2023-2027” report has been added to’s offering.

The NGS-based RNA-seq market is poised to grow by $3,753.73 mn during 2023-2027, accelerating at a CAGR of 15.34% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased adoption of next-generation sequencing methods, technological advancement in sequencing platforms, and the availability of wide range of next generation sequencing products.

The NGS-based RNA-seq market is segmented as below:


By End-user

  • Academic and research centers
  • Clinical research
  • Pharma companies
  • Hospitals

By Technology

  • Sequencing by synthesis
  • Ion semiconductor sequencing
  • Single-molecule real-time sequencing
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the NGS-based RNA-seq market covers the following areas:

  • NGS-based RNA-seq market sizing
  • NGS-based RNA-seq market forecast
  • NGS-based RNA-seq market industry analysis

Key Topics Covered:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by End-user

7 Market Segmentation by Technology

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

Companies Mentioned

  • Agilent Technologies Inc.
  • BGI Genomics Co. Ltd.
  • Brooks Automation Inc.
  • DNASTAR Inc.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Hamilton Bonaduz AG
  • Illumina Inc.
  • Precigen Inc.
  • Pacific Biosciences of California Inc.
  • PerkinElmer Inc.
  • PierianDx Inc.
  • Psomagen Inc.
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp.


For more information about this report visit

View source version on


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 12/22/2022 04:16 AM/DISC: 12/22/2022 04:17 AM